CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $1.61M invested in Can-Fite BioPharma in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$55.4K
2
+$39K
3
+$30K
4
RJA
Raymond James & Associates
Florida
+$22K
5
Morgan Stanley
Morgan Stanley
New York
+$21.2K

Top Sellers

1
-$57K
2
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.43M
2
$61K
3
$39K
4
$30K
5
$22K
6
$22K
7
$1K
8
–
9
–